查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030298

細胞分離市場－全球產業規模、佔有率、趨勢、機會、預測：按細胞類型、應用、地區和競爭格局分類，2021-2031年

Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cell Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球細胞分離市場預計將從 2025 年的 41.2 億美元成長到 2031 年的 57.5 億美元，複合年成長率為 5.71%。

細胞分離是臨床研究和生命科學領域的關鍵步驟，它涉及在保持無菌的前提下，從混合生物樣本中精確提取目標細胞群。市場成長的主要驅動力是人們對個人化醫療日益成長的需求，以及自體免疫疾病和癌症等慢性疾病發病率的上升。此外，細胞研究的快速發展以及在再生醫學、免疫學和腫瘤學等領域的廣泛應用也是推動市場成長的重要因素。再生醫學聯盟（ARM）的報告顯示，截至2024年第三季度，全球共有2,981家研發公司活躍於細胞和基因治療產業，反映了這些技術的廣泛應用。

市場概覽
預測期 2027-2031
市場規模：2025年 41.2億美元
市場規模：2031年 57.5億美元
複合年成長率：2026-2031年 5.71%
成長最快的細分市場 人類細胞
最大的市場 北美洲

生物製藥生產的持續成長以及政府對生命科學研究的大力投入進一步推動了這一強勁需求。儘管有這些正面因素，市場仍面臨一個重大障礙：先進細胞分離設備的高前期成本。這些高額資金需求可能會阻礙其廣泛應用，尤其是在新興市場和預算有限的小規模研究機構。

市場促進因素

再生醫學和細胞療法的蓬勃發展是全球細胞分離市場的主要驅動力，也因此對高純度、高活性細胞樣本的需求持續成長。幹細胞療法和CAR-T細胞療法等開創性治療方法在臨床開發和基礎研究中都高度依賴精準高效的細胞分離方法。隨著產業的日趨成熟，對可靠的細胞分離系統的需求也日益凸顯。為了支持該領域的巨額投資，再生醫學聯盟於2026年1月12日發布的《理由相信》報告顯示，2025年該產業的投資總額將達到111億美元，共達成216項資金籌措協議。這將直接加速尖端細胞分離技術在現代實驗室的應用。

同時，分離調查方法的持續進步正在改變市場格局，引入自動化、高效且損傷更小的分離流程。諸如先進的免疫磁分離和微流體技術等突破性技術，透過提高細胞活力、處理能力和樣品純度，克服了傳統方法的局限性。這些技術對於以所需的精度分離難以檢測的細胞類型至關重要，而這種精確度正是複雜生物學研究和個人化治療所必需的。例如，STEMCELL Technologies 和 Immudex 於 2025 年 11 月 18 日聯合發布了一款新產品，該產品採用了一種結合 Immudex 的 Dextramer® 試劑和 EasySep™ Release 陽性篩選技術的方案，能夠快速、溫和地富集抗原特異性T 細胞。更廣泛的科學研究經費也進一步推動了這項發展動能。例如，根據美國放射學會 (ACR) 2026 年 1 月 22 日發布的報告，美國國立衛生研究院 (NIH) 已為 2026 會計年度爭取到 472 億美元的基本預算，比 2025 年增加了 4.15 億美元。這確保了對市場突破的長期支持。

市場挑戰

先進細胞分離系統高昂的初始成本嚴重阻礙了其市場持續擴張。這些經濟障礙限制了關鍵技術的廣泛應用，尤其對新興市場和預算有限的小規模研究機構影響尤為顯著。專用設備、持續維護和必要耗材所需的巨額初始投資，嚴重消耗了這些機構的財政資源，限制了其參與先進治療方法開發和前沿細胞研究的能力。因此，這些高昂的設備成本對於致力於建立基礎研究能力的機構而言，構成了一道重大障礙。

這些局部的財務壓力因更廣泛的經濟因素而進一步加劇，這些因素可能會進一步限制研究實驗室的預算和營運範圍。例如，生物技術創新組織 (BIO) 在 2025 年 3 月進行的一項調查顯示，超過 50% 的生物技術公司預計，如果徵收某些關稅，它們在獲取和開展研究經費方面將面臨更大的挑戰。這凸顯了成本增加，特別是實驗室關鍵設備的成本增加，如何削弱研究潛力，並延緩細胞分離平台等關鍵工具的普及應用。最終，這種經濟障礙將阻礙人們獲得必要的科研基礎設施，減緩科學創新，並限制細胞分離方法在各個臨床和學術領域的推廣。

市場趨勢

對全面細胞數據日益成長的需求是推動單細胞分析技術快速發展的主要動力。這些技術需要能夠維持細胞完整性和活性的精密細胞分離技術。這一趨勢正在推動高精度、微創分離工具的進步，這些工具專為基於蛋白質組學和基因組學的單細胞分析的樣品製備而設計。現代研究人員越來越傾向於尋找能夠忠實模擬其體內自然生物學狀態的分離細胞，這推動了能夠最大限度地回收目標細胞並顯著降低細胞壓力的平台的發展。反映這一上升趨勢的是，Seeking Alpha 於 2026 年 2 月 12 日發布的一份報告指出，Bio-Rad 預計其生命科學部門（涵蓋單細胞分析儀器的核心業務）在 2026 年全年將保持約 4% 的成長。

影響全球細胞分離領域的另一個變革性趨勢是採用人工智慧 (AI) 來提高細胞表徵和分選的準確性和速度。人工智慧演算法目前已被廣泛用於自動化和最佳化從複雜的生物混合物中識別、分選和評估特定細胞群的過程。透過引入人工智慧，實驗室可以最大限度地減少人為錯誤，加快實驗流程，並識別細微的細胞表現型。這簡化了從樣品製備到數據解讀的整個流程，從而能夠為臨床和治療應用提供可重複的結果。為了佐證這項技術變革的重要性，《生物程序國際》(BioProcess International) 2026 年 4 月 8 日的報導報道稱，賽默飛世爾科技公司計劃在其 2026 年 10 億美元的 CDMO 投資戰略中，投資約 6500 萬美元用於數位化和人工智慧主導的能力建設。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球細胞分離市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 細胞類型（人類細胞、動物細胞）
    • 依應用領域（生物分子分離、癌症研究、幹細胞研究、體外診斷等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美細胞分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲細胞分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區細胞分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲細胞分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美細胞分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球細胞分離市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 5108

The Global cell isolation market is expected to expand from USD 4.12 billion in 2025 to USD 5.75 billion by 2031, reflecting a compound annual growth rate of 5.71%. Cell isolation, or cell separation, is an essential procedure in clinical research and the life sciences that entails accurately extracting targeted cell groups from mixed biological samples while maintaining sterility. Market growth is largely fueled by the escalating need for personalized treatments and the growing incidence of chronic conditions like autoimmune diseases and cancer. Additionally, the rapid advancement of cell-based studies and broadening uses in regenerative medicine, immunology, and oncology are major catalysts for this expansion. Highlighting the extensive use of these technologies, the Alliance for Regenerative Medicine (ARM) reported that 2,981 developers were actively engaged in the global cell and gene therapy industry as of the third quarter of 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.12 Billion
Market Size 2031USD 5.75 Billion
CAGR 2026-20315.71%
Fastest Growing SegmentHuman Cells
Largest MarketNorth America

This strong demand is further reinforced by the continuous increase in biopharmaceutical manufacturing and reliable government investments in life sciences research. Despite these positive indicators, the market encounters a major hurdle in the form of steep upfront expenses linked to sophisticated cell separation equipment. These heavy financial requirements can hinder widespread implementation, especially within emerging markets and smaller research facilities with limited budgets.

Market Driver

The widespread adoption of regenerative medicine and cell-based therapies acts as a primary catalyst for the global cell isolation market, generating a continuous need for exceptionally pure and viable cell samples. Pioneering treatments, such as stem cell therapies and CAR T-cell applications, depend heavily on accurate and effective cell separation methods for both clinical progression and preliminary research. As the industry matures, the requirement for dependable cell isolation systems becomes increasingly critical. Highlighting the immense financial backing in this sector, the Alliance for Regenerative Medicine's January 12, 2026 report, "Reasons to Believe," revealed that industry funding hit $11.1 billion across 216 financing events in 2025, which directly accelerates the integration of state-of-the-art cell separation technologies into modern laboratories.

At the same time, continuous technological upgrades in separation methodologies are transforming the market by introducing automated, highly efficient, and less damaging isolation processes. Breakthroughs such as refined immunomagnetic separation and microfluidics overcome historical constraints by boosting cell survival rates, throughput, and sample purity, which are vital for isolating elusive cell types with the exactness required for intricate biological studies and personalized treatments. For example, a collaborative launch by STEMCELL Technologies and Immudex on November 18, 2025, introduced a protocol merging Immudex's Dextramer(R) reagents with EasySep(TM) Release positive selection to swiftly and gently enrich antigen-specific T cells. This momentum is further backed by broader scientific funding, such as the National Institutes of Health securing a $47.2 billion base budget for fiscal year 2026-a $415 million rise from 2025, according to a January 22, 2026 report by the American College of Radiology-ensuring long-term support for market breakthroughs.

Market Challenge

The steep initial expenses tied to sophisticated cell separation systems pose a major roadblock to the continued expansion of the market. Such financial hurdles prevent the broad integration of these vital technologies, largely affecting emerging markets and smaller research facilities that operate with constrained capital budgets. The substantial upfront investment needed for specialized machinery, ongoing maintenance, and necessary consumables can severely deplete financial reserves, thereby limiting the capacity of these institutions to participate in advanced therapeutic development and cutting-edge cell-based studies. Consequently, these prohibitive equipment costs act as a significant barrier for entities aiming to establish foundational research capabilities.

These localized financial pressures are compounded by broader economic variables that can further restrict laboratory budgets and operational scope. Demonstrating the impact of rising costs, a March 2025 survey from the Biotechnology Innovation Organization (BIO) indicated that over 50% of biotech companies expected greater challenges in financing and executing research if specific tariffs were introduced. This highlights how heightened expenses, particularly concerning vital laboratory equipment, can diminish research potential and slow the adoption of essential tools like cell isolation platforms. Ultimately, this economic barrier denies crucial access to necessary research infrastructure, slowing down scientific innovation and confining the widespread use of cell separation methods across various clinical and academic disciplines.

Market Trends

The rising need for comprehensive cellular data is heavily driven by the rapid expansion of single-cell analysis methods, which require sophisticated cell isolation techniques capable of maintaining the integrity and viability of the cells. This movement is sparking advancements in highly precise and gentle separation tools tailored to prepare samples for detailed proteomic and genomic single-cell evaluations. Modern researchers increasingly demand separated cells that closely mimic their natural in vivo biological condition, prompting the creation of platforms that maximize target cell retrieval while significantly reducing cellular stress. Reflecting this upward trajectory, a February 12, 2026 report by Seeking Alpha noted that Bio-Rad expects its foundational Life Science division, which encompasses single-cell analytical instruments, to experience a growth rate of almost 4% throughout 2026.

Another transformative trend influencing the global cell isolation landscape is the incorporation of Artificial Intelligence (AI) to improve the accuracy and speed of cell characterization and selection. AI algorithms are now frequently utilized to automate and optimize the identification, sorting, and evaluation of specific cell groups within intricate biological mixtures. By deploying AI, laboratories can minimize manual errors, speed up experimental workflows, and recognize nuanced cellular phenotypes, streamlining the entire process from sample preparation to data interpretation to deliver reproducible results for clinical and therapeutic use. Underscoring the importance of this technological shift, an April 8, 2026 article from BioProcess International reported that Thermo Fisher Scientific intends to dedicate roughly $65 million to digital and AI-driven capabilities as a component of its $1 billion CDMO investment strategy for 2026.

Key Market Players

  • Becton, Dickinson & Company
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Terumo Corporation
  • PluriSelect Life Science UG & Co. KG
  • Danaher Corporation
  • STEMCELL Technologies Inc.
  • Corning Inc.
  • Akadeum Life Sciences Inc.

Report Scope

In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Isolation Market, By Cell Type

  • Human Cells
  • Animal Cells

Cell Isolation Market, By Application

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • In Vitro Diagnostics
  • Others

Cell Isolation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.

Available Customizations:

Global Cell Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Isolation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Cell Type (Human Cells, Animal Cells)
    • 5.2.2. By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In Vitro Diagnostics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cell Isolation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cell Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Isolation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Cell Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Cell Isolation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Cell Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Cell Isolation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Cell Type
        • 6.3.3.2.2. By Application

7. Europe Cell Isolation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cell Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell Isolation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cell Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Cell Isolation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cell Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Cell Isolation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cell Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Cell Isolation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cell Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Cell Isolation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cell Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Cell Isolation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cell Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Isolation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cell Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Cell Isolation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cell Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Cell Isolation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cell Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Cell Isolation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cell Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Cell Isolation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cell Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Cell Isolation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cell Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cell Isolation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cell Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Cell Isolation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cell Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Cell Isolation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cell Type
        • 9.3.3.2.2. By Application

10. South America Cell Isolation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cell Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Isolation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cell Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Cell Isolation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cell Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Cell Isolation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cell Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cell Isolation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson & Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck KGaA
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Bio-Rad Laboratories Inc.
  • 15.5. Terumo Corporation
  • 15.6. PluriSelect Life Science UG & Co. KG
  • 15.7. Danaher Corporation
  • 15.8. STEMCELL Technologies Inc.
  • 15.9. Corning Inc.
  • 15.10. Akadeum Life Sciences Inc.

16. Strategic Recommendations

17. About Us & Disclaimer